TL;DR
This study reveals that hidradenitis suppurativa (HS) is driven by an intrinsic defect in keratinocytes, leading to a chronic inflammatory state. By identifying an overproduction of pro-inflammatory cytokines and an altered antimicrobial peptide response in HS keratinocytes, the research offers a new perspective on the disease's pathogenesis, moving beyond solely immune cell involvement.
What Problem Does This Paper Address?
Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease affecting a significant portion of the population, yet its underlying causes remain poorly understood. Current therapeutic approaches often involve antibiotics and immunosuppressants, suggesting a role for the skin's immune response to its resident microflora. However, the "primum movens" – the initial trigger for this chronic inflammation – has been elusive. This paper aims to elucidate the fundamental cellular and molecular mechanisms driving HS, specifically investigating whether an intrinsic defect in skin cells, particularly keratinocytes, contributes to the persistent inflammation and susceptibility to infection characteristic of the disease.
Methods
The researchers employed a multi-pronged approach combining immunological and molecular analyses:
- Flow Cytometry: Used to quantify the frequency of specific T cell subsets (IL-17, IL-22, IFN-γ secreting CD4+ T cells) in peripheral blood mononuclear cells (PBMCs) and skin biopsies from HS patients and healthy donors (HD). They also analyzed chemokine receptor expression on these T cells to understand their homing potential.
- Quantitative Reverse Transcriptase PCR (qRT-PCR): Employed to measure the mRNA expression levels of various cytokines and chemokines in lesional and non-lesional skin samples.
- Transcriptomic Analysis (Microarray): Performed on skin and blood samples to identify differentially expressed genes and enriched biological pathways in HS patients compared to HD. This provided a broad overview of the molecular landscape.
- Keratinocyte Culture and Stimulation: Outer root sheath (ORS) keratinocytes were isolated from hair follicles of HS patients and HD. These cells were then cultured and stimulated with microbial products (e.g., MDP, Pam2CSK4) to assess their production of antimicrobial peptides (AMPs) and pro-inflammatory cytokines.
- Luminex Assay: Used to quantify the protein levels of various cytokines and chemokines secreted by keratinocytes in cell culture supernatants.
Datasets
The study utilized biological samples from:
- 18 patients with hidradenitis suppurativa (HS).
- 13 healthy donors (HD) for blood samples.
- Skin samples from healthy patients undergoing abdominoplasty or mammoplasty.
No new benchmarks were introduced; the study focused on analyzing existing biological samples and comparing them between the HS and HD groups.
Key Insights and Ideas
- T Cell Imbalance: While HS patients showed increased IL-17 and IL-22 producing CD4+ T cells in their blood, this was not mirrored by an increased frequency of IL-22 producing T cells in HS skin lesions. However, there was an increase in IL-17 and IFN-γ producing CD4+ T cells in HS skin.
- Keratinocyte Dysfunction is Central: The most striking finding is that keratinocytes isolated from HS hair follicles exhibit a distinct, pro-inflammatory phenotype. They constitutively secrete higher levels of certain inflammatory mediators and show an altered response to microbial stimulation.
- Altered Antimicrobial Peptide (AMP) Production: HS keratinocytes displayed a different pattern of AMP expression, with some key protective peptides being less effectively induced or even downregulated, potentially impairing the skin's first line of defense against pathogens.
- A Vicious Inflammatory Cycle: The study suggests that HS keratinocytes, when stimulated by microbial products, release IL-1β, which in turn triggers the release of other pro-inflammatory cytokines (IL-6, IL-8, TNF-α, IP-10, CCL5). This creates a self-perpetuating inflammatory loop.
- IL-17/IFN-γ "Th1-like" Cells in HS Skin: The presence of CD4+ T cells co-producing IL-17 and IFN-γ in HS perilesional and lesional skin, but not in HD skin, points to a specific inflammatory signature in the affected tissue.
Key Results
- Increased IL-17 and IL-22 in Blood: HS patients had significantly higher frequencies of IL-17A+ and IL-22+ CD4+ T cells in their PBMCs compared to HD.
- Increased IL-17 and IFN-γ in Skin: HS skin lesions showed a significantly higher frequency of IL-17A+ and IFN-γ+ CD4+ T cells compared to HD skin.
- Altered Cytokine/Chemokine Gene Expression in Skin: mRNA expression of IFN-γ, IL-10, IL-17, and CCL20 was significantly increased in HS skin, while CCL27 was decreased.
- Distinct AMP Expression in HS Keratinocytes: HS keratinocytes showed a 9-fold increased expression of S100A7 and a 7-fold increase in RNAse7 at baseline compared to HD. Conversely, hBD-1 expression was impaired.
- Pro-inflammatory Cytokine Secretion by HS Keratinocytes: HS keratinocytes constitutively secreted higher levels of IP-10 and CCL5. Upon stimulation with MDP or Pam2CSK4, they showed significantly increased IL-1β secretion, unlike HD keratinocytes.
Limitations and Future Work
- Heterogeneity of HS Patients: The authors acknowledge that the heterogeneous nature of HS patients and potential differences in experimental procedures could explain some discrepancies with other studies (e.g., regarding PBMC cytokine production).
- Unmeasured Differences: They also suggest that unmeasured differences in participants themselves might contribute to variations.
- Need for Further Therapeutic Strategies: The study highlights the need for future research to unravel the complex regulatory networks controlling keratinocyte inflammation to develop new therapeutic strategies for HS.
- Role of Notch Signaling: The paper briefly mentions the potential involvement of Notch signaling in HS keratinocyte dysfunction, suggesting this as a future avenue of investigation.
- AMP Production Complexity: The authors note that AMP production is complex, with multiple cell types contributing, and that further work is needed to fully understand the role of keratinocyte AMPs in HS.
Summary updated